Repare Therapeutics Inc. (RPTX) Tops Q4 EPS by 14c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q4 EPS of ($0.67), $0.14 better than the analyst estimate of ($0.81).

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• China semiconductor equipment imports grow 9% in July, Barclays comments
• ScanSource (SCSC) Tops Q4 EPS by 32c
• Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings